Project Details
Projekt
Regulation of microRNA-302a in human and mouse macrophages after stimulation with modified low density lipoproteins. The main focus of the research is to explore whether microRNA-302a contributes to the maintenance of cholesterol homeostasis and therefore has an important role in the pathogenesis of atherosclerosis
Applicant
Dr. Svenja Meiler
Subject Area
Cell Biology
Term
from 2012 to 2015
Project identifier
Deutsche Forschungsgemeinschaft (DFG) - Project number 220300215
Cholesterol and other lipids play key roles in many physiological processes. Aberrant cholesterol/lipid homeostasis has been linked to a number of diseases including atherosclerosis. Therefore control of cholesterol levels is essential to human health. In addition to classical transcription regulators, a class of small endogenous double-stranded RNAs termed microRNAs (miRs) has emerged as important modulators of many cellular and physiological processes that affect organism growth, development, homeostasis, and disease. Recent studies have shown that specific miRs are regulated in modified low-density lipoprotein-treated macrophages, which can affect the cholesterol homeostasis in the cell. However involvement of miR-302a in lipid metabolism in macrophages has not been investigated so far. The aim of this study is to determine the potential role of miR-302a on the expression of genes involved in cellular cholesterol transport of mouse and human macrophages. To identify target genes of miR-302a and to manipulate miR-302a expression to regulate those genes in vitro assays will be used. To indicate the influence of miR-302a regarding cellular cholesterol transport and further more atherosclerosis in vivo experiments will be carried out. In this way miR-302a could be identified as an important therapeutic target for suppressing atherogenesis.
DFG Programme
Research Fellowships
International Connection
Netherlands, USA
